Axxess Pharma, Inc. Signs Exclusive License Agreement in Canada, Latin America, Middle East and Africa
June 16 2010 - 7:00AM
Marketwired
Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company
specializing in the marketing and distribution of both prescription
and non-prescription medical products, is pleased to announce they
have signed an exclusive license agreement to manufacture and
distribute non-prescription drugs in Canada, Latin America, Middle
East and Africa. Axxess Pharma will also be the first company to
introduce a unique herbal, non-alcohol based antiseptic hand wash
and disinfectant to the Canadian market.
The Company is now marketing the medications under the Axxess
Pharma name. These products include antifungal, Bacterialcidal,
Corticoid ointment and creams.
Orders are currently being processed worldwide with a guarantee
of quick shipment. The Company anticipates revenues will increase
year over year by a minimum of 300 percent. Current annual global
sales within this market sector are estimated between $400 million
to $500 million.
"This exclusive license agreement will substantially increase
our revenue base and allow us to increase market share worldwide
under our brand name 'Axxess Pharma.' We are especially excited to
be the first company to introduce a unique herbal, non-alcoholic
antiseptic hand wash in Canada," stated Gerald Sequeira,
President/CEO. Consumers are becoming increasingly aware of the
dangers of alcohol based sanitizers. Most sanitizers in the market
today contain 60 percent to 90 percent alcohol (commonly ethyl or
isopropyl alcohol). Hospitals and consumers around the world are
becoming increasingly aware this alcohol is poisoning adults and
most importantly children and the elderly. Even the smallest use of
sanitizers which contain large concentrations of alcohol can lead
to several serious dangers including dizziness, headaches, blurred
speech and brain damage (in extreme cases). This new realization is
now creating a shift in demand to products such as our non-alcohol
based hand sanitizers. We are in prime position to capture
significant market share and revenue in this area," stated Mr.
Sequeira.
For more information, please contact Investor Relations at (973)
351-3868 or visit www.axxesspharma.com.
About Axxess Pharma, Inc.:
Axxess Pharma, Inc. is a specialty pharmaceutical company that
focuses on the marketing of dermatological, therapeutic
nutritionals, pain management and diagnostic products in Canada and
abroad since 1997. Axxess owns 22 established pharmaceutical
prescription products that have proven sales in Canada and
internationally. The company has an experienced management team and
field sales force to market products nationally to hospitals and
retail pharmacies as well as specialized practice areas including
Dermatology and Nephrology, Neurology and Urology.
Safe Harbor
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Taylor Capitol, Inc. Investor Relations Stephen Taylor
973-351-3868 Email Contact
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024